ImmuXell Biotech
Latest round
- Series A
Last raised
- Oct 2023
Total raised
- $14M
Investors
- 3
About ImmuXell Biotech
Established in 2021 and based in Shanghai, China, ImmuXell Biotech is a biotechnology company that focuses on providing tumor immune cell therapy services. As of 2023, the company's self-developed TCR-T cell therapy product targeting KRAS mutations completed an investigator-initiated clinical trial (IIT) for advanced pancreatic ductal adenocarcinoma, and is now in the IND filing preparation stage. The company focuses on tumor immune cell therapy services. In addition, its main products are novel immune cell formulations targeting solid tumors.
Who invested in ImmuXell Biotech
3 investors across 1 round
See all investors in ImmuXell Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Oct 31, 2023
Amount
$14M
Investors
Questions about ImmuXell Biotech
Who invested in ImmuXell Biotech?
ImmuXell Biotech has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ImmuXell Biotech raised?
ImmuXell Biotech has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ImmuXell Biotech last raise money?
ImmuXell Biotech's most recent round on record is a Series A, in Oct 2023.
What does ImmuXell Biotech do?
Established in 2021 and based in Shanghai, China, ImmuXell Biotech is a biotechnology company that focuses on providing tumor immune cell therapy services.
Where is ImmuXell Biotech headquartered?
ImmuXell Biotech is headquartered in Shanghai, China.
Which VCs invest in companies like ImmuXell Biotech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ImmuXell Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ImmuXell Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.